Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease

BACKGROUND: Retrospective observational studies may provide real-world evidence about long-acting muscarinic receptor antagonist (LAMA) effectiveness in reducing mortality or COPD-related readmission risk after a COPD hospitalization. Causal inference and competing risk statistical procedures aid in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Real World Outcomes
Main Authors: Roberts, Melissa H., Mapel, Douglas W., Petersen, Hans
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060983/
https://ncbi.nlm.nih.gov/pubmed/31792873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-019-00171-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados